Supporting Sponsor of Friends for Life Spring Refuel 2021
Friends for Life Spring Refuel 2021 Booth Hours
Live Exhibition Hall Hours (All Times Eastern US)
Friday, March 19: 5:00 - 8:00 pm
Saturday, March 20: 12:30 - 2:00 pm
Sunday, March 21: 12:30 - 2:00 pm
Special Video Presentation
A Season of Control - Interview with Mark Andrews
During Children with Diabetes Virtual Friends for Life Orlando 2020, we interviewed Baltimore Ravens Tight End Mark Andrews about what he is looking forward to during the upcoming football season, diabetes on and off the field, how he’ll be tracking time in range with help from his t:slim X2™ insulin pump with Control-IQ™ technology, and even his favorite low snack!
Virtual Booth Sessions
Company Corner with Tandem Diabetes Care
Meet with Tandem Diabetes Care representatives to learn more about the t:slim X2 Insulin Pump with Control-IQ Technology. This session will be open format for you to ask any questions you may have about Tandem Diabetes Care and our products.
Join us on Friday, Saturday, and Sunday. Click the links below.
Kids and parents are loving the t:slim X2™ insulin pump with Control-IQ® technology
We understand that kids want a say when it comes to choosing how to manage their diabetes. We’ve made that choice easier for the entire family by designing a system that helps to keep diabetes under control.
Learn More About t:slim and Control IQ
The T1D community sleeps better thanks to the t:slim X2™ insulin pump with Control-IQ® technology
For many people living with type 1 diabetes, a full-night’s rest feels like an unattainable prize. But with the t:slim X2™ insulin pump with Control-IQ® technology, so many members of our community are enjoying sleeping soundly for the first time in years! In their own words, hear how Control-IQ technology changed their lives – and their nights.
How Control-IQ Technology Works on the t:slim X2 Insulin Pump
This video provides a brief overview of how Control-IQ™ technology works with your t:slim X2™ insulin pump to help manage your diabetes on a day-to-day basis by predicting and helping prevent both highs and lows. The video explains how Control-IQ advanced hybrid closed-loop technology is designed to help increase time in range (70-180 mg/dL)* using Dexcom G6 CGM values to predict glucose levels 30 minutes ahead and adjust insulin delivery accordingly; including delivery of automatic correction boluses† as needed.
*As measured by CGM
† If glucose values are predicted to be above 180 mg/dL, Control-IQ technology calculates a correction bolus using the Personal Profile settings and a target of 110 mg/dL and delivers 60% of that value. It will do this up to once per hour as needed.
Resources About t:slim and Control IQ
Zoom Backgrounds
Important Safety Information:
RX ONLY.
Indications for Use:
t:slim X2 insulin pump
The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in individuals six years of age and greater. The pump is intended for single patient, home use and requires a prescription. The pump is indicated for use with NovoLog or Humalog U-100 insulin.
Control-IQ technology
Control-IQ technology is intended for use with a compatible integrated continuous glucose monitor (iCGM, sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater. Control-IQ technology is intended for single patient use. Control-IQ technology is indicated for use with NovoLog or Humalog U-100 insulin.
Contraindications and Warnings:
WARNING: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.
Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea.
Users of the t:slim X2 pump and Control-IQ technology must:
- be able and willing to use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use;
- test blood glucose levels as recommended by their healthcare provider;
- demonstrate adequate carb-counting skills;
- maintain sufficient diabetes self-care skills;
- see healthcare provider(s) regularly; and
- have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders;
The t:slim X2 pump, transmitter, and sensor must be removed before MRI, CT, or diathermy treatment.
Visit tandemdiabetes.com/safetyinfo for additional important safety information.
